A clinical trial of NVG-291 peptide drug demonstrates promising results for spinal cord injury patients, with participant ...
PORT JEFFERSON, Long Island -- Thirty-one-year-old Greg Durso usually needs a wheelchair to get around, but on Tuesday, the Connecticut man used cutting-edge technology to help him stand and walk at a ...
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback